LEIDEN, The Netherlands--(BUSINESS WIRE)--GenScript Biotech Europe BV announced that it has obtained CE marking for its SARS-CoV-2 diagnostic products to be sold as an in vitro diagnostic (“IVD”).
- Rapid real-time PCR test allows testing for SARS-CoV2 in only a few hours - Test kit to be made available via Curetis’ European sales channels - Synergies with Curetis Unyvero HPN panel for ...
- Synergies with Curetis Unyvero HPN panel for pneumonia testing for bacterial co-infections in Covid-19 patients The test will be made available to diagnostic laboratories in Europe through Curetis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results